+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Summit Therapeutics plc - logo

Summit Therapeutics is a biopharmaceutical company focussed on the development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. The company is developing Ezutromid, an utrophin modulator product candidate that is in Phase II clinical trials used for to treat Duchenne muscular dystrophy disease. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.

Gonorrhea R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Gonorrhea R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 94 pages
From
From
From
Gonorrhea R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Gonorrhea R&D Pipeline Analysis Report, H2-2018

  • Report
  • August 2018
  • 40 pages
From
From
From
From
From
From
Klebsiella pneumoniae Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Klebsiella pneumoniae Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 140 pages
From
Acinetobacter Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Acinetobacter Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 204 pages
From
From
From
Sepsis - Pipeline Review, H2 2019 - Product Thumbnail Image

Sepsis - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 367 pages
From
Loading Indicator
adroll